Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Minireview: Recent Developments in the Physiology and Pathology of the Lysophosphatidylinositol-Sensitive Receptor GPR55
Christopher M. Henstridge, Nariman Balenga, Julia Kargl, et al.
Molecular Endocrinology (2011) Vol. 25, Iss. 11, pp. 1835-1848
Open Access | Times Cited: 150

Showing 1-25 of 150 citing articles:

A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects
Lesley Taylor, Barry E. Gidal, Graham Blakey, et al.
CNS Drugs (2018) Vol. 32, Iss. 11, pp. 1053-1067
Open Access | Times Cited: 375
Emerging roles of lysophospholipids in health and disease
Shu Ting Tan, T. Ramesh, Xiu Ru Toh, et al.
Progress in Lipid Research (2020) Vol. 80, pp. 101068-101068
Open Access | Times Cited: 251
Progress in brain cannabinoid CB2 receptor research: From genes to behavior
Chloe J. Jordan, Zheng‐Xiong Xi
Neuroscience & Biobehavioral Reviews (2019) Vol. 98, pp. 208-220
Open Access | Times Cited: 169
Cannabinoid- and lysophosphatidylinositol-sensitive receptor GPR55 boosts neurotransmitter release at central synapses
Sergiy Sylantyev, Thomas P. Jensen, Ruth A. Ross, et al.
Proceedings of the National Academy of Sciences (2013) Vol. 110, Iss. 13, pp. 5193-5198
Open Access | Times Cited: 196
Cannabinoid receptors: nomenclature and pharmacological principles
Linda Console‐Bram, Jahan P. Marcu, Mary E. Abood
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2012) Vol. 38, Iss. 1, pp. 4-15
Open Access | Times Cited: 160
Cannabis Use and the Risk for Psychosis and Affective Disorders
Lucia Sideli, Harriet Quigley, Caterina La Cascia, et al.
Journal of Dual Diagnosis (2019) Vol. 16, Iss. 1, pp. 22-42
Closed Access | Times Cited: 113
The Endocannabinoid System as a Target in Cancer Diseases: Are We There Yet?
Estefanía Moreno, Milena Čavić, Ana Krivokuća, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 112
GPR55, a G-Protein Coupled Receptor for Lysophosphatidylinositol, Plays a Role in Motor Coordination
Chia‐Shan Wu, Hongmei Chen, Hao Sun, et al.
PLoS ONE (2013) Vol. 8, Iss. 4, pp. e60314-e60314
Open Access | Times Cited: 105
Targeting CB2-GPR55 Receptor Heteromers Modulates Cancer Cell Signaling
Estefanía Moreno, Clara Andradas, Mireia Medrano, et al.
Journal of Biological Chemistry (2014) Vol. 289, Iss. 32, pp. 21960-21972
Open Access | Times Cited: 105
GPR55 – a putative “type 3” cannabinoid receptor in inflammation
Hye-Won Yang, Juan Zhou, Christine Lehmann
Journal of Basic and Clinical Physiology and Pharmacology (2015) Vol. 27, Iss. 3, pp. 297-302
Open Access | Times Cited: 98
GPR55: A therapeutic target for Parkinson's disease?
Marta Celorrio, Estefanía Rojo-Bustamante, Diana Fernández‐Suárez, et al.
Neuropharmacology (2017) Vol. 125, pp. 319-332
Closed Access | Times Cited: 93
Lysophosphatidylinositols, from Cell Membrane Constituents to GPR55 Ligands
Mireille Alhouayek, Julien Masquelier, Giulio G. Muccioli
Trends in Pharmacological Sciences (2018) Vol. 39, Iss. 6, pp. 586-604
Closed Access | Times Cited: 89
A Phase 1, Open‐Label, Parallel‐Group, Single‐Dose Trial of the Pharmacokinetics and Safety of Cannabidiol (CBD) in Subjects With Mild to Severe Hepatic Impairment
Lesley Taylor, Julie C. Crockett, Bola Tayo, et al.
The Journal of Clinical Pharmacology (2019) Vol. 59, Iss. 8, pp. 1110-1119
Open Access | Times Cited: 85
Identification of the GPR55 Antagonist Binding Site Using a Novel Set of High-Potency GPR55 Selective Ligands
Evangelia Kotsikorou, Haleli Sharir, Derek M. Shore, et al.
Biochemistry (2013) Vol. 52, Iss. 52, pp. 9456-9469
Open Access | Times Cited: 98
Lysophosphatidylinositol signalling: New wine from an old bottle
Roberto Piñeiro, Marco Falasca
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2012) Vol. 1821, Iss. 4, pp. 694-705
Closed Access | Times Cited: 94
Cannabidiol as a potential treatment for psychosis
Chris D. Schubart, Iris E. Sommer, Paolo Fusar‐Poli, et al.
European Neuropsychopharmacology (2013) Vol. 24, Iss. 1, pp. 51-64
Closed Access | Times Cited: 94
The differential characterization of GPR55 receptor in human peripheral blood reveals a distinctive expression in monocytes and NK cells and a proinflammatory role in these innate cells
Valerio Chiurchiù, Mirko Lanuti, Marco De Bardi, et al.
International Immunology (2014) Vol. 27, Iss. 3, pp. 153-160
Open Access | Times Cited: 91
The orphan receptor GPR55 drives skin carcinogenesis and is upregulated in human squamous cell carcinomas
Eduardo Pérez-Gómez, Clara Andradas, J.M. Flores, et al.
Oncogene (2012) Vol. 32, Iss. 20, pp. 2534-2542
Open Access | Times Cited: 90
A Selective Antagonist Reveals a Potential Role of G Protein–Coupled Receptor 55 in Platelet and Endothelial Cell Function
Julia Kargl, Andrew J. Brown, Liisa Andersen, et al.
Journal of Pharmacology and Experimental Therapeutics (2013) Vol. 346, Iss. 1, pp. 54-66
Closed Access | Times Cited: 88
The GPR55 antagonist CID16020046 protects against intestinal inflammation
Angela Stančić, Katharina Jandl, Carina Hasenöhrl, et al.
Neurogastroenterology & Motility (2015) Vol. 27, Iss. 10, pp. 1432-1445
Open Access | Times Cited: 87
The Cannabinoid Receptor CB1 Modulates the Signaling Properties of the Lysophosphatidylinositol Receptor GPR55
Julia Kargl, Nariman Balenga, Gerald P. Parzmair, et al.
Journal of Biological Chemistry (2012) Vol. 287, Iss. 53, pp. 44234-44248
Open Access | Times Cited: 87
GPR55 promotes migration and adhesion of colon cancer cells indicating a role in metastasis
Julia Kargl, Liisa Andersen, Carina Hasenöhrl, et al.
British Journal of Pharmacology (2015) Vol. 173, Iss. 1, pp. 142-154
Open Access | Times Cited: 87
CB1 and GPR55 receptors are co-expressed and form heteromers in rat and monkey striatum
Eva Martínez‐Pinilla, Irene Reyes‐Resina, Ainhoa Oñatibia‐Astibia, et al.
Experimental Neurology (2014) Vol. 261, pp. 44-52
Closed Access | Times Cited: 85
Cannabinoid receptor 2 as a potential therapeutic target in rheumatoid arthritis
Shin Fukuda, Hitoshi Kohsaka, Aiko Takayasu, et al.
BMC Musculoskeletal Disorders (2014) Vol. 15, Iss. 1
Open Access | Times Cited: 82
Medical Cannabis for Older Patients
Amir Minerbi, Winfried Häuser, Mary‐Ann Fitzcharles
Drugs & Aging (2018) Vol. 36, Iss. 1, pp. 39-51
Closed Access | Times Cited: 82
Page 1 - Next Page

Scroll to top